Objective Measures of Social Visual Engagement Aid Early Diagnosis of Autism

TUESDAY, Sept. 12, 2023 (HealthDay News) -- Objective measurements of social visual engagement through eye tracking-based measures can be used to aid in autism diagnosis and assessment, according to a study published online Sept. 5 in JAMA Network Open.
Warren Jones, Ph.D., from Children’s Healthcare of Atlanta, and colleagues developed an objective, eye tracking-based index test to aid in early diagnosis and assessment of autism in children younger than 3 years. The analysis included data from 1,089 children (719 children in the discovery study and 370 children in the replication study).
The researchers found that in the discovery study, the area under the receiver operating characteristic curve was 0.90, sensitivity was 81.9 percent, and specificity was 89.9 percent. Findings were similar in the replication study (0.89, 80.6 percent, and 82.3 percent, respectively). Eye-tracking test results correlated with expert clinical assessments of children’s individual levels of ability, explaining 68.6 percent of variance in reference standard assessments of social disability, 63.4 percent for verbal ability, and 49.0 percent of nonverbal cognitive ability.
"These results offer the prospect of an objective biomarker to aid in autism diagnosis and assessment," the authors write.
Several authors disclosed ties to EarliTec Diagnostics, which helped with eye-tracking data processing and analysis.
Related Posts
FDA Panel to Vote on First RSV Vaccine Given in Pregnancy to Protect Infants
THURSDAY, May 18, 2023 (HealthDay News) -- The first RSV vaccine designed to...
Pet Store Puppies Passing Drug-Resistant Bacteria to People
WEDNESDAY, Sept. 15, 2021 (HealthDay News) -- It's hard to resist those big,...
Las habilidades mentales se deterioran con la edad, pero los adultos mayores mejoran en otras áreas: estudio
LUNES, 19 de septiembre de 2022 (HealthDay News) -- Un nuevo estudio sobre la...
Prostate MRI Has Independent Screening Value
WEDNESDAY, Aug. 23, 2023 (HealthDay News) -- Prostate magnetic resonance imaging...
